Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward

Affiliations

Review

Ume L Abbas et al. Proc Natl Acad Sci U S A. 2002.

. 2002 Oct 15;99(21):13377-8.

doi: 10.1073/pnas.212518999. Epub 2002 Oct 7.

¹ Division of Infectious Diseases, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.

No abstract available

Comment on

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
Oxenius A, Price DA, Günthard HF, Dawson SJ, Fagard C, Perrin L, Fischer M, Weber R, Plana M, García F, Hirschel B, McLean A, Phillips RE. Oxenius A, et al. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13747-52. doi: 10.1073/pnas.202372199. Epub 2002 Oct 7. Proc Natl Acad Sci U S A. 2002. PMID: 12370434 Free PMC article. Clinical Trial.

1. Palella F J J, Delaney K M, Moorman A C, Loveless M O, Fuhrer J, Satten G A, Aschman D J, Scott M S, Holmberg D. N Engl J Med. 1998;338:853–860. - PubMed
1. Hogg R S, Heath K V, Yip B, Craib K J P, O'Shaughnessy M V, Schechter M T, Montaner J S G. J Am Med Assoc. 1998;279:450–454. - PubMed
1. Havlir D. Proc Natl Acad Sci USA. 2002;99:4–6. - PMC - PubMed
1. Lori F, Lewis M G, Xu J, Varga G, Zinn D E, Jr, Crabbs C, Wagner W, Greenhouse J, Silvera P, Yalley-Ogunro J, et al. Science. 2000;290:1591–1593. - PubMed
1. Dybul M, Chun T W, Yoder C, Hidalgo B, Belson M, Hertogs K, Larder B, Dewar R L, Fox C H, Hallahan C W, et al. Proc Natl Acad Sci USA. 2001;98:15161–15166. - PMC - PubMed